This is a preview of subscription content, log in via an institution to check access.
Notes
The analysis assumed that, in the absence of Medicare Part D, average outcomes in the two groups would follow parallel paths over time. Costs were adjusted to 2010 values.
Reference
Kircher SM, et al. Impact of Medicare Part D on out-of-pocket drug costs and medical use for patients with cancer. Cancer : 24 Jun 2014. Available from: URL: http://doi.org/10.1002/cncr.28898
Rights and permissions
About this article
Cite this article
Medicare Part D curbs costs for US elderly with cancer. PharmacoEcon Outcomes News 707, 5 (2014). https://doi.org/10.1007/s40274-014-1387-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1387-9